AU2002303969A1 - Molecular iodine pharmaceutical composition - Google Patents

Molecular iodine pharmaceutical composition

Info

Publication number
AU2002303969A1
AU2002303969A1 AU2002303969A AU2002303969A AU2002303969A1 AU 2002303969 A1 AU2002303969 A1 AU 2002303969A1 AU 2002303969 A AU2002303969 A AU 2002303969A AU 2002303969 A AU2002303969 A AU 2002303969A AU 2002303969 A1 AU2002303969 A1 AU 2002303969A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
molecular iodine
iodine pharmaceutical
molecular
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002303969A
Inventor
Jongjun Duan
Jack Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symbollon Pharmaceuticals Inc
Original Assignee
Symbollon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Pharmaceuticals Inc filed Critical Symbollon Pharmaceuticals Inc
Publication of AU2002303969A1 publication Critical patent/AU2002303969A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002303969A 2002-06-04 2002-06-04 Molecular iodine pharmaceutical composition Abandoned AU2002303969A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/017736 WO2003103689A1 (en) 2002-06-04 2002-06-04 Molecular iodine pharmaceutical composition

Publications (1)

Publication Number Publication Date
AU2002303969A1 true AU2002303969A1 (en) 2003-12-22

Family

ID=29731310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002303969A Abandoned AU2002303969A1 (en) 2002-06-04 2002-06-04 Molecular iodine pharmaceutical composition

Country Status (2)

Country Link
AU (1) AU2002303969A1 (en)
WO (1) WO2003103689A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018053335A1 (en) * 2016-09-16 2018-03-22 Iogen Llc Oral molecular iodine composition and method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081232A (en) * 1960-12-27 1963-03-12 Warner Lambert Pharmaceutical Iodine preparation and method of disinfecting the skin
US4012504A (en) * 1972-05-12 1977-03-15 Velvet Chemical Co. Iodine mineral oil solution for preventing bovine mastitis
JPS58222024A (en) * 1982-06-18 1983-12-23 Tokitaka Mori Antitumor agent
AU6887600A (en) * 1999-08-17 2001-04-30 Jaroslav Hanzel Composition for preventing iodine deficiency

Also Published As

Publication number Publication date
WO2003103689A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
AU2009201465A1 (en) Pharmaceutical Compositions with Improved Dissolution
AU2003250372A1 (en) Pharmaceutical composition
EP1425019A4 (en) Pharmaceutical composition
AU2002302147A1 (en) Pharmaceutical composition
AU2003267231A1 (en) Pharmaceutical compositions with improved dissolution
AU2003284460A1 (en) Medicinal composition
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003280799A1 (en) Medicinal composition
AU2002303969A1 (en) Molecular iodine pharmaceutical composition
AU2003280678A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AU2003303591A1 (en) Pharmaceutical compositions with improved dissolution
AUPS188302A0 (en) Pharmaceutical composition
AU2002335161A1 (en) Medicinal composition
AUPS167102A0 (en) Pharmaceutical composition
AUPS124202A0 (en) Pharmaceutical composition
AU2003902322A0 (en) Pharmaceutical composition
AU2002100921A4 (en) Pharmaceutical composition
AU2003242346A1 (en) Drug composition
GB0217703D0 (en) Pharmaceutical composition
AU2003211835A1 (en) Antibacterial pharmaceutical composition
AU2002316418A1 (en) Pharmaceutical composition
AUPR430501A0 (en) Pharmaceutical composition
AUPR668401A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase